View Future GrowthGem Aromatics 過去の業績過去 基準チェック /16Gem Aromaticsの収益は年間平均-1.8%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間6.5% 6.5%割合で 増加しています。 Gem Aromaticsの自己資本利益率は0.3%であり、純利益率は0.4%です。主要情報-1.82%収益成長率-73.55%EPS成長率Chemicals 業界の成長17.68%収益成長率6.53%株主資本利益率0.32%ネット・マージン0.39%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • May 23Full year 2026 earnings released: EPS: ₹0.28 (vs ₹11.39 in FY 2025)Full year 2026 results: EPS: ₹0.28 (down from ₹11.39 in FY 2025). Revenue: ₹3.67b (down 27% from FY 2025). Net income: ₹14.3m (down 97% from FY 2025). Profit margin: 0.4% (down from 11% in FY 2025). The decrease in margin was driven by lower revenue.お知らせ • May 18Gem Aromatics Limited to Report Q4, 2026 Results on May 21, 2026Gem Aromatics Limited announced that they will report Q4, 2026 results on May 21, 2026Reported Earnings • Jan 28Third quarter 2026 earnings released: ₹1.04 loss per share (vs ₹3.74 profit in 3Q 2025)Third quarter 2026 results: ₹1.04 loss per share (down from ₹3.74 profit in 3Q 2025). Revenue: ₹772.5m (down 48% from 3Q 2025). Net loss: ₹49.9m (down 129% from profit in 3Q 2025).お知らせ • Jan 21Gem Aromatics Limited to Report Q3, 2026 Results on Jan 27, 2026Gem Aromatics Limited announced that they will report Q3, 2026 results on Jan 27, 2026分析記事 • Nov 27Gem Aromatics' (NSE:GEMAROMA) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Gem Aromatics Limited ( NSE:GEMAROMA ) was disappointing to investors, with a...Reported Earnings • Nov 15Second quarter 2026 earnings released: ₹0.04 loss per share (vs ₹3.74 profit in 2Q 2025)Second quarter 2026 results: ₹0.04 loss per share (down from ₹3.74 profit in 2Q 2025). Revenue: ₹905.1m (down 40% from 2Q 2025). Net loss: ₹25.8m (down 115% from profit in 2Q 2025).すべての更新を表示Recent updatesReported Earnings • May 23Full year 2026 earnings released: EPS: ₹0.28 (vs ₹11.39 in FY 2025)Full year 2026 results: EPS: ₹0.28 (down from ₹11.39 in FY 2025). Revenue: ₹3.67b (down 27% from FY 2025). Net income: ₹14.3m (down 97% from FY 2025). Profit margin: 0.4% (down from 11% in FY 2025). The decrease in margin was driven by lower revenue.お知らせ • May 18Gem Aromatics Limited to Report Q4, 2026 Results on May 21, 2026Gem Aromatics Limited announced that they will report Q4, 2026 results on May 21, 2026New Risk • Mar 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.24b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹9.24b market cap, or US$99.9m).分析記事 • Feb 09Subdued Growth No Barrier To Gem Aromatics Limited (NSE:GEMAROMA) With Shares Advancing 25%Gem Aromatics Limited ( NSE:GEMAROMA ) shareholders would be excited to see that the share price has had a great month...New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin).Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹193, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 22x in the Chemicals industry in India.Reported Earnings • Jan 28Third quarter 2026 earnings released: ₹1.04 loss per share (vs ₹3.74 profit in 3Q 2025)Third quarter 2026 results: ₹1.04 loss per share (down from ₹3.74 profit in 3Q 2025). Revenue: ₹772.5m (down 48% from 3Q 2025). Net loss: ₹49.9m (down 129% from profit in 3Q 2025).お知らせ • Jan 21Gem Aromatics Limited to Report Q3, 2026 Results on Jan 27, 2026Gem Aromatics Limited announced that they will report Q3, 2026 results on Jan 27, 2026Valuation Update With 7 Day Price Move • Dec 05Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 24x in the Chemicals industry in India.分析記事 • Nov 27Gem Aromatics' (NSE:GEMAROMA) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Gem Aromatics Limited ( NSE:GEMAROMA ) was disappointing to investors, with a...New Risk • Nov 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.84b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (40% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹8.84b market cap, or US$99.2m).Reported Earnings • Nov 15Second quarter 2026 earnings released: ₹0.04 loss per share (vs ₹3.74 profit in 2Q 2025)Second quarter 2026 results: ₹0.04 loss per share (down from ₹3.74 profit in 2Q 2025). Revenue: ₹905.1m (down 40% from 2Q 2025). Net loss: ₹25.8m (down 115% from profit in 2Q 2025).お知らせ • Oct 16Gem Aromatics Limited to Report Q2, 2026 Results on Nov 13, 2025Gem Aromatics Limited announced that they will report Q2, 2026 results on Nov 13, 2025Reported Earnings • Sep 13First quarter 2026 earnings releasedFirst quarter 2026 results: EPS: ₹1.70. Net income: ₹79.8m (up ₹79.8m from 1Q 2025).お知らせ • Sep 09Gem Aromatics Limited to Report Q1, 2026 Results on Sep 12, 2025Gem Aromatics Limited announced that they will report Q1, 2026 results on Sep 12, 2025Board Change • Aug 26High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shubhangi Umbarkar was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.収支内訳Gem Aromatics の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NSEI:GEMAROMA 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費31 Mar 263,66514164031 Dec 254,583280137030 Sep 254,762405126030 Jun 254,989528138031 Mar 255,040534128031 Mar 244,525501111031 Mar 234,248447108031 Mar 223,42039797031 Mar 213,059232740質の高い収益: GEMAROMAは 高品質の収益 を持っています。利益率の向上: GEMAROMAの現在の純利益率 (0.4%)は、昨年(10.6%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: GEMAROMAの収益は過去 5 年間で年間1.8%減少しました。成長の加速: GEMAROMAは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: GEMAROMAは過去 1 年間で収益成長率がマイナス ( -97.3% ) となったため、 Chemicals業界平均 ( 13.7% ) と比較することが困難です。株主資本利益率高いROE: GEMAROMAの 自己資本利益率 ( 0.3% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/13 19:13終値2026/07/13 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Gem Aromatics Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 23Full year 2026 earnings released: EPS: ₹0.28 (vs ₹11.39 in FY 2025)Full year 2026 results: EPS: ₹0.28 (down from ₹11.39 in FY 2025). Revenue: ₹3.67b (down 27% from FY 2025). Net income: ₹14.3m (down 97% from FY 2025). Profit margin: 0.4% (down from 11% in FY 2025). The decrease in margin was driven by lower revenue.
お知らせ • May 18Gem Aromatics Limited to Report Q4, 2026 Results on May 21, 2026Gem Aromatics Limited announced that they will report Q4, 2026 results on May 21, 2026
Reported Earnings • Jan 28Third quarter 2026 earnings released: ₹1.04 loss per share (vs ₹3.74 profit in 3Q 2025)Third quarter 2026 results: ₹1.04 loss per share (down from ₹3.74 profit in 3Q 2025). Revenue: ₹772.5m (down 48% from 3Q 2025). Net loss: ₹49.9m (down 129% from profit in 3Q 2025).
お知らせ • Jan 21Gem Aromatics Limited to Report Q3, 2026 Results on Jan 27, 2026Gem Aromatics Limited announced that they will report Q3, 2026 results on Jan 27, 2026
分析記事 • Nov 27Gem Aromatics' (NSE:GEMAROMA) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Gem Aromatics Limited ( NSE:GEMAROMA ) was disappointing to investors, with a...
Reported Earnings • Nov 15Second quarter 2026 earnings released: ₹0.04 loss per share (vs ₹3.74 profit in 2Q 2025)Second quarter 2026 results: ₹0.04 loss per share (down from ₹3.74 profit in 2Q 2025). Revenue: ₹905.1m (down 40% from 2Q 2025). Net loss: ₹25.8m (down 115% from profit in 2Q 2025).
Reported Earnings • May 23Full year 2026 earnings released: EPS: ₹0.28 (vs ₹11.39 in FY 2025)Full year 2026 results: EPS: ₹0.28 (down from ₹11.39 in FY 2025). Revenue: ₹3.67b (down 27% from FY 2025). Net income: ₹14.3m (down 97% from FY 2025). Profit margin: 0.4% (down from 11% in FY 2025). The decrease in margin was driven by lower revenue.
お知らせ • May 18Gem Aromatics Limited to Report Q4, 2026 Results on May 21, 2026Gem Aromatics Limited announced that they will report Q4, 2026 results on May 21, 2026
New Risk • Mar 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.24b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹9.24b market cap, or US$99.9m).
分析記事 • Feb 09Subdued Growth No Barrier To Gem Aromatics Limited (NSE:GEMAROMA) With Shares Advancing 25%Gem Aromatics Limited ( NSE:GEMAROMA ) shareholders would be excited to see that the share price has had a great month...
New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin).
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹193, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 22x in the Chemicals industry in India.
Reported Earnings • Jan 28Third quarter 2026 earnings released: ₹1.04 loss per share (vs ₹3.74 profit in 3Q 2025)Third quarter 2026 results: ₹1.04 loss per share (down from ₹3.74 profit in 3Q 2025). Revenue: ₹772.5m (down 48% from 3Q 2025). Net loss: ₹49.9m (down 129% from profit in 3Q 2025).
お知らせ • Jan 21Gem Aromatics Limited to Report Q3, 2026 Results on Jan 27, 2026Gem Aromatics Limited announced that they will report Q3, 2026 results on Jan 27, 2026
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 24x in the Chemicals industry in India.
分析記事 • Nov 27Gem Aromatics' (NSE:GEMAROMA) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Gem Aromatics Limited ( NSE:GEMAROMA ) was disappointing to investors, with a...
New Risk • Nov 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.84b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (40% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹8.84b market cap, or US$99.2m).
Reported Earnings • Nov 15Second quarter 2026 earnings released: ₹0.04 loss per share (vs ₹3.74 profit in 2Q 2025)Second quarter 2026 results: ₹0.04 loss per share (down from ₹3.74 profit in 2Q 2025). Revenue: ₹905.1m (down 40% from 2Q 2025). Net loss: ₹25.8m (down 115% from profit in 2Q 2025).
お知らせ • Oct 16Gem Aromatics Limited to Report Q2, 2026 Results on Nov 13, 2025Gem Aromatics Limited announced that they will report Q2, 2026 results on Nov 13, 2025
Reported Earnings • Sep 13First quarter 2026 earnings releasedFirst quarter 2026 results: EPS: ₹1.70. Net income: ₹79.8m (up ₹79.8m from 1Q 2025).
お知らせ • Sep 09Gem Aromatics Limited to Report Q1, 2026 Results on Sep 12, 2025Gem Aromatics Limited announced that they will report Q1, 2026 results on Sep 12, 2025
Board Change • Aug 26High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shubhangi Umbarkar was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.